Información de la revista
Vol. 39. Núm. 4.
Páginas 256-257 (Mayo 2015)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 39. Núm. 4.
Páginas 256-257 (Mayo 2015)
Scientific Letter
Acceso a texto completo
Shock following subcutaneous injections of polymethylmethacrylate
Shock después de inyecciones subcutáneas de polimetilmetacrilato
Visitas
6138
M. Boattini
Autor para correspondencia
matteoboattini@gmail.com

Corresponding author.
, A.R. Francisco, R. Cavaco, J. Rodrigues, L. Bento
Unidade de Urgência Médica, Hospital São José, Centro Hospitalar Lisboa Central, Portugal
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (1)
Table 1. PiCCO haemodynamic monitoring.
Texto completo

A 35-year-old transsexual (male to female) went to emergency with 24h of mild fever, cough and dyspnoea. Four days before he had been submitted to multiple gluteus subcutaneous injections of polymethylmethacrylate (PMMA) microspheres. Patient had a past medical history of uncontrolled hypertension.

On admission patient had Glasgow Coma Scale Score of 15, tachypnea and tachycardia, with central cyanosis and was sweating. No fever. Blood pressure was 100/70mmHg and respiratory rate 40/min. Arterial blood gas analysis under 15l/min oxygen therapy by a non-rebreathing mask with reservoir showed global respiratory insufficiency and sever acidemia (pH 7.22, pO2 31mmHg, pCO2 49mmHg, HCO3 17.6mEq/L, SatO2 55%, lactate 6.17mmol/L). Heart auscultation revealed audible S1 and S2 and chest auscultation revealed bilateral rales. The remaining physical examination just was unremarkable with exception of mild redness, warmth and swelling of the gluteus. No fluctuation was detected and no indication for surgical approach was considered. Chest X-ray showed bilateral lung infiltrates (Fig. 1A). At this time was intubated and mechanically ventilated.

Figure 1.

1A. Chest X-ray showing bilateral lung infiltrates. 1B-E. Chest CT angiographyshowing bilateral consolidations with air-bronchograms and ground-glass-appearing opacities suggestive of alveolar damage.

(0,15MB).

On intensive care unit (ICU) admission presented with hypotension, tachycardia, oligoanuric renal failure, mixed acidemia and pO2/FiO2 ratio of 40. Biochemistry showed: normocytic normochromic anaemia, high white blood cells count, coagulation times prolonged, acute renal lesion with hyperkalemia, hyperbilirubinemia 1.49mg/dL [0.3–1.2], conjugated bilirubin 0.79 [0–0.2], hepatic cytolysis high lactate dehydrogenase and C-reactive protein. Patient was started on empirical antibiotic therapy with meropenem due to the inflammatory signs in gluteus.

Electrocardiogram showed sinus tachycardia with S1Q3T3 pattern. Computed tomography angiography ruled out pulmonary embolism and disclosed bilateral consolidations with air-bronchograms and ground-glass-appearing opacities suggestive of alveolar damage (Fig. 1B–E). Transthoracic echocardiogram revealed normal left ventricular systolic function with no contractility alterations, valve dysfunctions or pericardial effusion.

Pulse contour cardiac output (PiCCO) catheter was placed and haemodynamic monitoring showed low cardiac index (CI), low intrathoracic blood volume index (ITBVI), low central venous oxygen saturation (cvSatO2), high venous-to-arterial CO2 gap (pCO2 gap), high extravascular lung water index (EVLWI) and normal systemic vascular resistance (SVR) on norepinephrine 0.55μg/kg/min. Distributive shock (DS) with vasoplegia, functional hypovolemia and pulmonary oedema complicated with multiple organ dysfunction syndrome (MODS) was diagnosed (Table 1). Patient was started on vasopressors and continuous renal replacement technique. He developed severe (pO2/FiO2 ratio100)1 acute respiratory distress syndrome (ARDS) with need of prone position and curarization.

Table 1.

PiCCO haemodynamic monitoring.

  On admission  After 12After 24After 36After 48After 72After 96
Norepinephrine, μg/kg/min  0.55  0.18  0.05 
BP, mmHg  151/66  139/66  145/80  148/89  90/54  179/103  121/70 
HR, bpm  101  100  78  63  62  54  79 
CVP, cm H213  16  14  16  12  13  10 
CI (2.8–3.4)  2.31  3.19  2.89  2.83  2.94  2.33  3.5 
SVR (770–1500)  1169  731  1034  1115  630  1720  725 
EVLWI (3–7)  21  16.7  12.4  11.3  9.8  8.2  12.4 
ITBVI (850–1000)  486  594  619  676  714  766  1043 
paO2, mmHg  61.5  95.3  122  116  70  162.6  111 
aSatO276  94.1  96.6  96  88  99.3  98 
pvO2, mmHg  29.9  54.8  52  40  41  32.9  43 
cvSatO254  79.9  79.4  67  62  61.1  72 
pCO2 gap  19  14.9  13.3  5.2 
FiO2 (21–100%)  100  100  80  65  50  70  75 
PEEP, cm H216  16  16  16  14  10  12 
Lactate, mmol/L  8.8  6.7  2.35  2.11  1.67  2.69  1.5 
Hb, g/dL  10.9  10.8  9.6  8.6  7.7  8.5  8.3 

BP, blood pressure; HR, heart rate; CVP, central venous pressure; CI, cardiac index; SVR, systemic vascular resistance; EVLWI, extravascular lung water index; ITBVI, intrathoracic blood volume index; paO2, arterial oxygen partial pressure; aSatO2, arterial oxygen saturation; pvO2, venous oxygen partial pressure; cvSatO2, central venous oxygen saturation; pCO2 gap, venous-to-arterial CO2 gap; FiO2, fraction of inspired oxygen; PEEP, positive end-expiratory pressure; Hb, haemoglobin.

Serologies for HIV, HBV, HCV, EBV, CMV, Mycoplasma pneumoniae and respiratory virus were negative. Tracheobronchial aspirate, uroculture and pneumococcal and Legionella urinary antigen tests were negative. Three sets of blood culture specimens exhibited no growth. Meropenem stopped on the 5th day of therapy.

Patient remained apyretic, inflammatory markers decreased and gluteus inflammatory signs improved rapidly. Patient remained under continuous renal replacement technique for 5 days with gradual recovery of renal function and vasopressor support was stopped on 2nd day. He was mechanically ventilated for 15 days and was extubated on 16th day.

Chest CT with significant reduction of pulmonary infiltrates. Laboratory tests evidenced recovery of hepatic function with correction of the coagulation disorder.

Patient was transferred to intermediate care on 17th day and then to the general ward, requiring only physical rehabilitation.

Shock is a high mortality acute syndrome characterized by cellular dysoxia, and can lead if not quickly and appropriately managed to organ failure and death. It is classically rated has hypovolemic, cardiogenic, obstructive or distributive. The first three are associated with low CI while distributive shock is associated with normal or supranormal levels of CI,1 impaired distribution of microvascular blood flow and metabolic distress. DS occurs mainly during systemic inflammatory response syndrome (SIRS) which can be due to infectious or non-infectious causes. The most common aetiology of DS is septic shock. Non-infectious causes include burns, pancreatitis, toxic shock syndrome, anaphylaxis and drugs or toxins. PMMA is a no biodegradable injectable filling used for a variety of conditions such as percutaneous vertebroplasty and cosmetic soft tissue filling. PMMA subcutaneous injections local complications are nodules, filler migration and granulomas. Mostly described following percutaneous vertebroplasty systemic complications include pulmonary embolism,2 pulmonary embolism with ARDS,3 ventricular perforation,4 intracardiac embolism,5 aortic embolism,6 renal embolism7 and deep vein thrombosis.8

Our patient never had fever. Inflammatory markers decreased rapidly and did not relapse after meropenem has been stopped. No pathogenic organisms were isolated. We assisted to a favourable evolution even in absence of antibiotherapy. These facts make infectious aetiology less probable. Most probable hypothesis due to patient's history of PMMA gluteus subcutaneous injections four days before, absence of positive culture results and favourable evolution just with organ support therapy is SIRS triggered by chemical insult induced by PMMA. To the best of our knowledge, this is the first case reported in literature of shock and MODS secondary to subcutaneous injection of PMMA.

Conflicts of interest

All the authors have reported no conflicts of interest.

References
[1]
J.L. Vincent, D. De Backer.
Circulatory shock.
N Engl J Med, 369 (2013), pp. 1726-1734
[2]
J.N. MacTaggart, I.I. Pipinos, J.M. Johanning, T.G. Lynch.
Acrylic cement pulmonary embolus masquerading as an embolized central venous catheter fragment.
J Vasc Surg, 43 (2006), pp. 180-183
[3]
K.Y. Yoo, S.W. Jeong, W. Yoon, J. Lee.
Acute respiratory distress syndrome associated with pulmonary cement embolism following percutaneous vertebroplasty with polymethylmethacrylate.
Spine, 29 (2004), pp. E294-E297
[4]
I. Gosev, L. Nascimben, P.H. Huang, L. Mauri, M. Steigner, A. Mizuguchi, et al.
Right ventricular perforation and pulmonary embolism with polymethylmethacrylate cement after percutaneous kyphoplasty.
Circulation, 127 (2013), pp. 1251-1253
[5]
J.S. Lee, Y.S. Jeong, S.G. Ahn.
Intracardiac bone cement embolism.
[6]
M. Mozaffar, M.R. Radpay, H. Zirakzadeh, P. Nabavizadeh, M.R. Sobhiye, R. Motiei Langroudi.
Intra-arterial injection of acrylic cement as a complication of percutaneous vertebroplasty.
J Vasc Surg, 56 (2012), pp. 1107-1109
[7]
S.E. Chung, S.H. Lee, T.H. Kim, K.H. Yoo, B.J. Jo.
Renal cement embolism during percutaneous vertebroplasty.
Eur Spine J, 15 (2006), pp. 590-594
[8]
S.M. Kim, S.K. Min, H.J. Jae, S.I. Min, J. Ha, S.J. Kim.
Successful thrombolysis, angioplasty, and stenting of delayed thrombosis in the vena cava following percutaneous vertebroplasty with polymethylmethacrylate cement.
J Vasc Surg, 56 (2012), pp. 1119-1123
Copyright © 2014. Elsevier España, S.L.U. and SEMICYUC
Idiomas
Medicina Intensiva
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?